Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

20.99
Real-Time Quote
As of 2:34pm ET
 -0.16 / -0.76%
Today’s Change
18.16
Today|||52-Week Range
22.98
+8.42%
Year-to-Date
Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion
May 22 / Zacks.com - Paid Partner Content
Ionis (IONS) Stock Falls Despite Positive Inotersen Data
May 16 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications
May 19 / Zacks.com - Paid Partner Content
Mylan (MYL) Beats on Q1 Earnings, Revenues Miss Estimates
May 10 / Zacks.com - Paid Partner Content
Hikma Trims Full Year Revenue Guidance After Advair Diskus Delay
May 19 / TheStreet.com - Paid Partner Content
Epizyme (EPZM) Incurs Narrower-than-Expected Loss in Q1
May 09 / Zacks.com - Paid Partner Content
Huge Downgrades Loom Over Hikma Pharmaceuticals
May 17 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close21.15
Today’s open21.09
Day’s range20.99 - 21.68
Volume1,018
Average volume (3 months)3,340
Market cap$104.3B
Dividend yield4.88%
Data as of 2:34pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-90.47%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+2.96%
P/E ratio--
Price/Sales2.52
Price/Book74.30

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$37.6B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts